|
Symbol
|
1025BC | 1029BC | 1065BC | 1066BC | 1048BC | 1068BC | 1062BC | 1074BC | 1069BC | 1094BC | 1097BC | 1104BC | 1111BC | 1114BC | 1115BC | 1116BC | 1122BC | 1128BC | 1129BC | 1136BC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible |
|
Sous-jacent
|
Alphabet Inc. (A) / Microsoft Corp. / Qualcomm Inc. | EURO STOXX 50 / Nikkei 225 / S&P 500 / SMI | Nestlé S.A. / Novartis AG / Roche PS | EURO STOXX 50 PR Index / S&P 500 Index / SMI Index | AXA S.A. / Compagnie de Saint-Gobain S.A. / Deutsche Telekom AG | Barry Callebaut AG / Clariant AG / SIG Combibloc | Alcon / Straumann Hldg. AG / Tecan Group AG | EURO STOXX 50 PR Index / S&P 500 Index / SMI Index | Baloise / Swiss Re / Zurich | EURO STOXX 50 PR Index / S&P 500 Index / SMI Index | Compagnie Financière Richemont SA / Lonza Group N / Swiss RE AG | Compagnie Financière Richemont SA / Logitech International SA / Sika AG / UBS Group AG | Geberit AG / Sika AG / Straumann Hldg. AG | Lonza Group N / Sandoz Group AG / Straumann Hldg. AG | Companie Financière Richemont SA / Logitech International SA / UBS Group AG | ABB N / SGS S.A. Ltd. / Sika AG | Sika AG / Straumann Hldg. AG / Swatch Group I | Givaudan / Partners Group Hldg. AG / Sonova Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Ems-Chemie Hldg. AG / Lonza Group N / Sika AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
18.11.2026 | 25.11.2026 | 11.09.2026 | 17.03.2027 | 26.02.2027 | 04.09.2026 | 07.09.2026 | 20.03.2028 | 21.09.2026 | 04.09.2026 | 10.12.2026 | 30.06.2027 | 08.10.2026 | 16.07.2027 | 30.07.2027 | 04.08.2027 | 25.02.2027 | 03.03.2027 | 05.03.2027 | 18.09.2026 |
| Demande | 99,09 | 101,30 | 101,40 | 100,91 | 98,24 | - | - | 100,75 | 101,27 | - | 102,62 | 102,16 | 78,51 | 98,99 | 100,89 | 97,18 | 99,47 | 64,25 | 96,88 | 101,15 |
| Offre | 99,88 | 102,10 | 102,20 | 101,71 | 99,02 | - | - | 101,55 | 102,07 | - | 103,43 | 102,97 | - | 99,78 | 101,69 | 97,95 | 100,26 | 64,76 | 97,65 | 101,95 |